home / stock / govxw / govxw news

GOVXW News and Press, GeoVax Labs Inc. Warrants From 03/23/21

Stock Information
Company Name: GeoVax Labs Inc. Warrants
Stock Symbol: GOVXW
Market: NASDAQ
Website: geovax.com
Menu
GOVXW GOVXW Quote GOVXW Short GOVXW News GOVXW Articles GOVXW Message Board
Get GOVXW Alerts

News, Short Squeeze, Breakout and More Instantly...
GOVXW - GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update

COVID-19 Vaccine Designed as Single-Dose Against Multiple Strains Immuno-Oncology Programs Advancing ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing immunotherapie...
GOVXW - GeoVax to Participate in Benzinga Biotech Small Cap Conference

GeoVax Chairman & CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc . (NasdaqCM: GOVX) (&#...

GOVXW - GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update

Conference call to be held Wednesday, March 24, at 8:00 a.m. Eastern Time ATLANTA, GA, March 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious dise...

GOVXW - GeoVax Expands and Strengthens Intellectual Property Portfolio

Filings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology Atlanta, GA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developin...
GOVXW - GeoVax to Present at the H.C. Wainwright Global Life Sciences Conference

Virtual Conference to be Held March 9-10, 2021 ATLANTA, GA, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, announced ...

GOVXW - Registration Now Open For Tribe Public's Webinar Event "Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond" Featuring GeoVax's CEO & CFO On March 3, 2021

Meet with GeoVax CEO David Dodd & CFO Mark Reynolds who will Deliver a Presentation Titled “ Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond ” ATLANTA, GA, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMedi...

GOVXW - GeoVax Announces Closing of $10.3 Million Bought Deal Offering

Atlanta, GA, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announce...
GOVXW - GeoVax Announces Pricing of $9.0 Million Bought Deal Offering

ATLANTA, GA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announ...

GOVXW - GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development

Company Focused on Single-dose Vaccine Against Multiple COVID Strains ATLANTA, GA, Jan. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and...

GOVXW - GeoVax to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

GeoVax Also Participating in BIO@JPM During “J.P. Morgan Week 2021” ATLANTA, GA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc . (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infecti...
Previous 10 Next 10